The Public Health Agency of Canada has ordered 28,000 doses of anthrax vaccine.
Artemisinin is an effective treatment for malaria, but access to it has been limited by how difficult it is to grow the plant from which it’s derived.
Omadacycline is the first in a new class of tetracyclines offering a broad-spectrum activity against Gram-positive, Gram-negative and atypical bacteria.
Researchers are pioneering technology to allow people with minimal training to produce medication, including diagnostic tools, vaccines, and drugs, anywhere.
This article offers an overview of the response to the 2001 anthrax attacks in the United States as well as current response planning.
Researchers outlined a strategy to target an Achilles' heel shared by all known types of Ebola virus.
A study finds that a mass drug administration (MDA) in Monrovia, Liberia, during the Ebola outbreak appears to have reduced the incidence of malaria throughout the city.
Researchers report the minimum serum concentrations required to protect mice against 10 times a 50% lethal dose of ricin.
Doctors in Sierra Leone treated approximately 100 Ebola patients with a combination of atorvastatin and irbesartan.
The US Biomedical Advanced Research and Development Authority (BARDA) and Regeneron Pharmaceuticals have partnered to develop a pair of antibodies to prevent and treat Middle East Respiratory Syndrome (MERS).